rs11599236 — SORCS3 SORCS3 Neurotrophin Sorting

The Brain's Neurotrophin Gatekeeper — SORCS3 and the Mood-Memory Interface

Your brain constantly decides how strongly to respond to its own growth signals. Brain-derived neurotrophic factor (BDNF)¹¹ Brain-derived neurotrophic factor (BDNF)
BDNF is a protein that promotes the survival, growth, and differentiation of neurons and synapses. It is one of the most important regulators of synaptic plasticity, learning, and emotional resilience. Low BDNF has been repeatedly linked to depression, anxiety, and cognitive decline is among the most potent of these signals — yet unbridled BDNF activity would be disruptive. The SORCS3 gene encodes a molecular gatekeeper that sorts the BDNF receptor TrkB between active surface positions and intracellular compartments, calibrating how much BDNF signaling actually reaches the synapse. Genetic variation at this locus has now emerged as one of the more robust molecular links between synaptic neurotrophin trafficking and psychiatric risk in the human genome.

The Mechanism

SORCS3 belongs to the VPS10 domain-containing receptor family²² VPS10 domain-containing receptor family
A family of type-I transmembrane proteins that act as intracellular sorting receptors, routing cargo proteins between cellular compartments. The family includes SORTILIN, SORCS1, SORCS2, and SORCS3 — all critical for neuronal protein trafficking. The VPS10 (vacuolar protein sorting 10) domain is the cargo-binding domain first characterized in yeast. In neurons, SORCS3 and its close relative SORCS1 function as [intracellular trafficking receptors for TrkB | Tropomyosin-related kinase B (TrkB) is the primary high-affinity receptor for BDNF. When BDNF binds TrkB at the cell surface, it triggers downstream signaling cascades that support synaptic plasticity, neuronal survival, and mood regulation], routing the receptor away from the synaptic surface and attenuating BDNF signaling.

A 2018 mouse knockout study³³ 2018 mouse knockout study
Subkhangulova A et al. SORCS1 and SORCS3 control energy balance and orexigenic peptide production. EMBO Rep, 2018 showed that neurons lacking both SORCS1 and SORCS3 display elevated TrkB phosphorylation following BDNF application — confirming that these receptors normally brake TrkB activation. The rs11599236 variant sits within an intron of SORCS3, in a position likely to influence gene expression rather than protein structure. Critically, a systematic analysis of 46 independent SORCS3 SNPs found that alleles linked to better psychiatric outcomes were consistently associated with higher SORCS3 expression⁴⁴ alleles linked to better psychiatric outcomes were consistently associated with higher SORCS3 expression
Kamran M et al. Independent Associated SNPs at SORCS3 and Its Protein Interactors for Multiple Brain-Related Disorders and Traits. Genes (Basel), 2023. This direction of effect — more SORCS3 protein equals better outcomes — points to a loss-of-function mechanism, where variants that reduce SORCS3 expression allow TrkB to accumulate at inappropriate synaptic locations, dysregulating the pro-neurotrophin / mature-neurotrophin balance at the synapse.

Beyond BDNF trafficking, SORCS3 interacts with p75NTR (the pan-neurotrophin receptor), promoting its internalization and lysosomal degradation. p75NTR is the primary receptor for the immature precursor form of BDNF (proBDNF), which has opposite effects to mature BDNF — promoting apoptosis and long-term depression at synapses rather than survival and potentiation. Dysregulated p75NTR activity is implicated in synaptic weakening associated with chronic stress and depression.

The Evidence

The association between rs11599236 and mood-related traits is among the most replicated SORCS3 findings in the literature. In the GWAS Catalog, this single variant is associated with at least six psychiatric and affective phenotypes spanning independent large-scale studies:

Mood instability and negative affect. The C allele at rs11599236 is associated with reduced subjective wellbeing (beta = -0.0074, p = 1×10⁻¹⁵, N > 300,000) and mood instability (p = 5×10⁻¹⁰) in population-based GWAS. The T allele is associated with increased ratings of feeling miserable (z-score beta = 7.05, p = 2×10⁻¹²) and higher neuroticism scores (p = 7×10⁻⁸ to p = 3×10⁻¹⁹ across independent cohorts).

Psychiatric cross-disorder risk. In the Psychiatric Genomics Consortium cross-disorder analysis spanning ADHD, autism spectrum disorder, bipolar disorder, major depressive disorder, and schizophrenia simultaneously, rs11599236 emerged as genome-wide significant (z-score beta = 6.19, p = 6×10⁻¹⁰), highlighting SORCS3 as a pleiotropic risk locus shared across neuropsychiatric conditions.

ADHD. A 2023 mega-GWAS⁵⁵ 2023 mega-GWAS
Demontis D et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet, 2023 of 38,691 ADHD cases and 186,843 controls identified SORCS3 as one of 27 genome-wide significant loci, with convergent evidence from both common variants and an elevated burden of rare protein-truncating variants in SORCS3 among ADHD cases.

Autism. Tag SNPs within SORCS3 (rs9787523 and rs3750261) showed nominal association with autism in a Han Chinese replication study⁶⁶ Han Chinese replication study
Heliyon 2024 of 757 trios, and the gene has appeared in multiple independent autism GWAS datasets.

Neurodegeneration. SORCS3 expression is significantly reduced in Alzheimer's disease brain tissue compared to controls (p = 5.1×10⁻⁵⁷⁷ p = 5.1×10⁻⁵
Reitz C et al. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP). Transl Psychiatry, 2013), and SORCS3 knockdown increases amyloid precursor protein (APP) processing by threefold — a direct functional link to the amyloid cascade. Non-coding SORCS3 variants were associated with dementia in women in a whole-genome sequencing study of the Women's Health Initiative cohort.

Practical Actions

For carriers of one or two C alleles, the actionable insight centers on supporting BDNF-TrkB signaling and maintaining synaptic neurotrophin balance. The evidence base for specific interventions is mostly mechanistic and derived, but the biological logic is clear: if SORCS3 hypofunction allows pro-neurotrophin signaling to dominate, strategies that boost mature BDNF availability and reduce chronic stress-mediated BDNF depletion are rational targets.

The single most evidence-backed modulator of BDNF expression is aerobic exercise — specifically continuous, moderate-intensity effort that reliably increases serum BDNF and hippocampal BDNF mRNA. This is distinct from generic exercise advice: the target is BDNF amplification in the context of a receptor that has reduced trafficking fidelity. Sleep quality independently regulates BDNF protein levels, with sleep deprivation robustly suppressing BDNF expression. Omega-3 DHA is incorporated into neuronal membranes and supports TrkB receptor signaling efficiency. Magnesium deficiency is associated with dysregulated neurotrophin signaling and increased anxiety-like behavior in animal models.

Interactions

SORCS3 sits in a gene family alongside SORCS1 and SORCS2, which interact with overlapping but distinct cargo sets. Variants in SORCS1 (rs10790256, rs600879) and SORCS2 have been independently associated with Alzheimer's risk and psychiatric phenotypes — raising the possibility that multiple VPS10-receptor variants compound their effects on neurotrophin trafficking in the same individual. SORCS3 gene-sets are enriched for synaptic biology⁸⁸ synaptic biology
Specifically, 15 biological process terms related to synapse organization, postsynaptic processes, and synaptic signaling were over-represented in SORCS3-associated genes in the Kamran et al. 2023 analysis, overlapping substantially with the biological pathways implicated by schizophrenia and bipolar disorder GWAS — suggesting that rs11599236 may act additively with variants in DRD2 (rs1800497), COMT (rs4680), and BDNF (rs6265) that alter the same dopamine-neurotrophin signaling axis.